During the earliest stages of embryonic development, the totipotent zygote proliferates and differentiates, generating diverse populations of cells that will ultimately form the organs and tissues of a mature organism. These early events dictate the course and success of the developing organism. Thus, it is critical that the pathways regulating these early developmental transitions are elucidated in order to diagnose and understand early pregnancy loss, as well as to advance stem cell technologies and infertility therapies. Most studies have concentrated on the role of transcriptional regulation, which fails to account for the fact that gene expression is dictated as much by the rate of mRNA decay as by the rate of RNA synthesis. In this proposal, we investigate the role of a conserved and highly selective RNA degradation pathway - Nonsense-Mediated RNA Decay (NMD). The overarching hypothesis of this proposal is that NMD is critical for early embryo development because it influences specific differentiation events through its ability to regulate the decay rate of key RNA transcripts in a stage-specific manner. In support, NMD degrades RNAs encoding developmental regulators and mouse KO studies have demonstrated that global loss of several NMD factors leads to early embryonic lethality, with defects evident during pre- and peri-implantation stages. To date, no studies have examined the underlying mechanism. Another outstanding issue in the field is how NMD is regulated. This is critical to understand, as shifts in NMD magnitude during development are predicted to trigger alterations in the stability of scores of RNAs. A breakthrough is our recent discovery of a potent repressor of NMD ? UPF3A. Undetectable in most adult tissues, UPF3A is highly expressed in the early embryo, and loss of UPF3A in mice leads to lethality during the peri- implantation stage of embryo development.
The first Aim of this proposal is to use existing mouse KO models to elucidate the roles of NMD?including the necessity of its repression by UPF3A?in the developmental progression of early embryos in vivo. To pinpoint NMD's mechanism of action, we will use single-cell transcriptome analysis, as this will allow us to (i) identify the specific embryonic cell subsets acted upon by NMD and UPF3A, (ii) define the repertoire of mRNAs degraded by NMD in the cell subsets in which NMD acts, and (iii) identify shifts in NMD activity that occur within the embryo as development proceeds.
The second Aim i s to elucidate the molecular mechanisms underlying NMD's essential roles in early embryogenesis. Leveraging our discovery that NMD is critical for dictating germ layer cell fate in embryonic stem cells (ESCs), we will use ?mimic? and ?rescue? approaches to identify the specific mRNAs that must be degraded by NMD to drive hESC differentiation decisions. To understand how NMD regulation influences these events, we will study the developmental and molecular roles of the NMD repressor, UPF3A, in hESC differentiation. Together these proposed studies will define?for the first time?a RNA decay network critical for early developmental events, akin to the pioneering studies defining transcriptional networks in development.

Public Health Relevance

Despite decades of research, the pathways governing early embryo development remain poorly understood, which has thwarted advances in several clinical areas, including early pregnancy loss and infertility. This proposal is focused on NMD, a highly conserved and selective RNA decay pathway whose loss leads to embryonic lethality and is critical for cell fate decisions in undifferentiated human stem cells. Our proposed study will delineate?for the first time?the developmental and molecular roles of this post-transcriptional pathway in early embryo development, providing a conceptually new direction towards the diagnosis and treatment of miscarriage and infertility.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD093846-02
Application #
9724492
Study Section
Molecular Genetics B Study Section (MGB)
Program Officer
Ravindranath, Neelakanta
Project Start
2018-07-01
Project End
2023-03-31
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
2
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093